141MO Pathological Response and Early Survival Data According to TNBCtype4 Classifier in Operable Triple-Negative Breast Cancer (TNBC) Treated with Neoadjuvant Carboplatin and DocetaxelI. Echavarria Diaz-Guardamino,S. Lopez-Tarruella Cobo,M. Del Monte-Millan,E. Alvarez,Y. Jerez,F. Moreno Anton,J. A. Garcia Saenz,T. Massarrah,I. Ocana,M. Cebollero,A. I. Ballesteros Garcia,U. Bohn Sarmiento,H. Gomez,H. A. Fuentes,B. Herrero Lopez,S. Gamez Casado,O. Bueno, M. J. Jimenez-Santos,M. Roche-Molina,M. Martin JimenezAnnals of oncology（2022）引用 2|浏览35暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
